Sipeki, S <br/><br/>
Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering.  [electronic resource] 

 -  Cellular signalling  Dec 1999 
 - 885-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0898-6568 
<br/><br/><label>Standard No.: </label>10.1016/s0898-6568(99)00060-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Hepatocellular--pathology<br/>Cell Movement--drug effects<br/>Chromones--pharmacology<br/>Cycloheximide--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Flavonoids--pharmacology<br/>Hepatocyte Growth Factor--pharmacology<br/>Humans<br/>Liver Neoplasms--pathology<br/>MAP Kinase Signaling System--drug effects<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Morpholines--pharmacology<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation--drug effects<br/>Protein Processing, Post-Translational--drug effects<br/>Protein Synthesis Inhibitors--pharmacology<br/>Proto-Oncogene Proteins--physiology<br/>Proto-Oncogene Proteins c-cbl<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Tumor Cells, Cultured--drug effects<br/>Ubiquitin-Protein Ligases